2 Followers on Owler

Prospect Venture Partners

Read more
Alex Barkas's photo - Managing Director of Prospect Venture Partners

Managing Director

Alex Barkas

CEO Approval Rating

70/100

Est. Annual Revenue
$13.3M
Est. Employees
10
Sector

Update Industry

Prospect Venture Partners Acquisitions

No recent acquisitions found related to Prospect Venture Partners

Prospect Venture Partners Funding History

No recent funding data found related to Prospect Venture Partners

Prospect Venture Partners Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

SentreHEART develops, manufactures and delivers remote suture delivery and tissue closure devices.
$25M
Sep 21, 2016
Series D
Aug 01, 2019
NGM Bio is a clinical stage biopharmaceutical company that develops biologic drugs for the treatment of cardio-metabolic and liver disease.
$20.7M
Oct 08, 2014
Series D
Apr 03, 2019
Nora develops therapeutics to address unmet clinical needs in reproductive medicine.
$18M
Apr 16, 2014
Series B
-
Element Science develops a wearable therapeutic device that detects and treats arrhythmias.
$12.5M
Mar 04, 2014
Equity
-
NinePoint Medical designs and develops Optical Coherence Tomography imaging systems for the evaluation of human tissue microstructure.
$34.6M
Mar 02, 2014
Series B
-

These are all the companies that Prospect Venture Partners has invested in. Prospect Venture Partners has invested 29 companies and its latest investment was SentreHEART in Sep 21,. SentreHEART develops, manufactures and delivers remote suture delivery and tissue closure devices.

Prospect Venture Partners News

Social Media

Prospect Venture Partners Headquarters

435 Tasso St Suite 200

Palo Alto, California94301

650-327-8800

Driving Directions »

Trending Companies

Prospect Venture Partners Summary

ABOUT

Overview

Prospect Venture Partners is a venture capital firm that focuses on investing in outstanding biopharmaceutical and medical device companies.  Prospect Venture Partners was founded in 06/1997. Prospect Venture Partners' headquarters is located in Palo ...

CEO

Prospect Venture Partners's Managing Director, Alex Barkas, currently has an approval rating of 70%. Prospect Venture Partners's primary competitors are

Frequently Asked Questions about Prospect Venture Partners

  1. When was Prospect Venture Partners founded?

    Prospect Venture Partners was founded in 06/1997
  2. Who is Prospect Venture Partners's CEO?

    Prospect Venture Partners's CEO is Alex Barkas
  3. How much revenue does Prospect Venture Partners generate?

    Prospect Venture Partners generates $13.3M in revenue
  4. How much funding does Prospect Venture Partners have?

    Prospect Venture Partners has historically raised $0 in funding
  1. Where is Prospect Venture Partners's headquarters?

    Prospect Venture Partners's headquarters is in Palo Alto California, USA
  2. How many employees does Prospect Venture Partners have?

    Prospect Venture Partners has 10 employees
  3. Who has Prospect Venture Partners invested in?

    Prospect Venture Partners's has invested in companies such as SentreHEART, NGM Bio, Nora Therapeutics